BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4154121)

  • 1. Prevention of exercise-induced asthma by indoramin.
    Bianco S; Griffin JP; Kamburoff PL; Prime FJ
    Br Med J; 1974 Oct; 4(5935):18-20. PubMed ID: 4154121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: Prevention of exercise-induced asthma by indoramin.
    Br Med J; 1974 Dec; 4(5947):770-1. PubMed ID: 4155341
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Prevention of exercise-induced asthma by indoramin.
    Godfrey S
    Br Med J; 1974 Nov; 4(5942):469. PubMed ID: 4425932
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of arterial hypertension with a new alpha-blocker, indoramin.
    Carballo R; Conde L; Lapelle M; Suarez J
    Curr Med Res Opin; 1974; 2(8):437-43. PubMed ID: 4155664
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug prevention of bronchial asthma: inhibition of histamine and exercise-induced asthma by a new anti-anaphylactic oral preparation (ketotifen) (author's transl)].
    Wüthrich B; Radielovic P
    Dtsch Med Wochenschr; 1978 Nov; 103(47):1865-9. PubMed ID: 30613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of an alpha-adrenoreceptor blocking drug (indoramin) in exercise-induced bronchoconstriction.
    Seale JP; Anderson SD; Lindsay DA
    Scand J Respir Dis; 1976; 57(6):261-6. PubMed ID: 189384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-adrenoreceptor blockade with indoramin in hypertension.
    Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(3):343-8. PubMed ID: 6191130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further observations on the experimental antidysrhythmic activity of indoramin hydrochloride.
    Rashid S; Alps BJ
    J Pharm Pharmacol; 1973 Sep; 25(9):700-4. PubMed ID: 4148504
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
    Boakes AJ; Prichard BN; Teoh PC
    Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-adrenergic blockade in severe asthma.
    Utting JA
    Br J Dis Chest; 1979 Jul; 73(3):317-8. PubMed ID: 45254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzamidopiperidines. 3. Carbocyclic derivatives related to indoramin.
    Archibald JL; Fairbrother P; Jackson JL
    J Med Chem; 1974 Jul; 17(7):739-45. PubMed ID: 4151791
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic studies of indoramin in man.
    Royds RB; Coltart DJ; Lockhart JD
    Clin Pharmacol Ther; 1972; 13(3):380-92. PubMed ID: 4402080
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of an alpha-adrenergic receptor blocking drug on histamine sensitivity in bronchial asthma.
    Gaddie J; Legge JS; Petrie G; Palmer KN
    Br J Dis Chest; 1972 Apr; 66(2):141-6. PubMed ID: 4402506
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial of an alpha-adrenolytic drug (indoramin) for nocturnal enuresis.
    Shaffer D; Hedge B; Stephenson J
    Dev Med Child Neurol; 1978 Apr; 20(2):183-8. PubMed ID: 25217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
    Bache RJ; Homans DC; Schwartz JS; Dai XZ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):232-7. PubMed ID: 2896237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-adrenoceptor blocking effect of indoramin on human isolated smooth muscle.
    Variava DH; Turner P
    J Pharm Pharmacol; 1973 Aug; 25(8):629-32. PubMed ID: 4148431
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term trial of an alpha adrenoceptor blocking drug (Indoramin) in asthma. A preliminary report.
    Black JL; Temple DM; Anderson SD
    Scand J Respir Dis; 1978; 59(6):307-12. PubMed ID: 373090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of RMI 81968, a combined alpha- and beta-adrenergic receptor blocking agent, on histamine-induced bronchoconstriction in the dog.
    Cheng HC; Reavis OK; Woodward JK
    Pharmacology; 1980; 20(2):111-4. PubMed ID: 6104338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
    Kramer R; Rosendorff C; Bloom D
    S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of indoramin, a new antihypertensive agent.
    Lewis PJ; George CF; Dollery CT
    Eur J Clin Pharmacol; 1973 Dec; 6(4):211-6. PubMed ID: 4359995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.